PT-141 (Bremelanotide) also written PT 141 or PT141 is a synthetic cyclic peptide from the melanocortin family, studied in research as an agonist at central melanocortin receptors (notably MC4R)
Patients with pre-existing subclinical nerve issues, perhaps from metabolic stress , vitamin deficiencies, or genetic predisposition, may respond differently to GLP-1 receptor activation than neurologically healthy patients
Alsumali A, Lautsch D, Kowal S, Li Q, Campbell C, Rajpathak S, et al
Second, GLP-1 drugs have shown an incredible capacity for weight loss, but the complications and side effects, as well as the cost often make it prohibitive for long-term use